IBD is mainly used to describe ulcerative colitis and Crohn’s disease, whose symptoms include abdominal pain, cramps or swelling, recurring or bloody diarrhoea, weight loss and extreme tiredness.

"Crohn's can affect basically anywhere in the gut, from the mouth to the anus," said UCSF Fresno's Dr. Maricela Rangel-Garcia. "Ulcerative colitis is usually just limited to the colon." ...

About 10 million people globally live with inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn’s disease. There is currently no cure for IBD.

Discover tips for managing your social life. Learn skills for coping with the stigma and mental health challenges of Crohn’s and UC. Living with Crohn’s or ulcerative colitis has its challenges.

F resenius Kabi has entered a global licensing agreement for the commercialisation of Polpharma Biologics’s vedolizumab ...

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis (UC) after a phase 2 study revealed ...

1. Chan SSM, Chen Y, Casey K, et al. Obesity is associated with increased risk of Crohn’s disease, but not ulcerative colitis: A pooled analysis of five prospective cohort studies.

Ulcerative colitis (UC) causes inflammation in the lining of your colon, or large intestine. It's one type of inflammatory bowel disease (IBD). Crohn's disease is another type. More than 3 million ...

We found that prior to diagnosis, this mixture of chemicals was linked with increased risk of both ulcerative colitis and Crohn's disease at 6-10 years before diagnosis, but not at time points ...

COLUMBUS (WCMH) — Central Ohio Take Steps kicked off Saturday morning in Dublin Coffman Park to raise awareness and fund research to find a cure for Crohn’s disease and ulcerative colitis ...

Mirikizumab correlated with a greater reduction in disease severity among patients with ulcerative colitis and moderate to severe Crohn’s disease, according to a poster presentation at the Crohn ...